BR9708720A - Pharmaceutical composition and process for the treatment of HIV dementia. - Google Patents

Pharmaceutical composition and process for the treatment of HIV dementia.

Info

Publication number
BR9708720A
BR9708720A BR9708720-3A BR9708720A BR9708720A BR 9708720 A BR9708720 A BR 9708720A BR 9708720 A BR9708720 A BR 9708720A BR 9708720 A BR9708720 A BR 9708720A
Authority
BR
Brazil
Prior art keywords
treatment
pharmaceutical composition
hiv
dementia
hiv dementia
Prior art date
Application number
BR9708720-3A
Other languages
Portuguese (pt)
Inventor
William Garland
Original Assignee
Centaur Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals filed Critical Centaur Pharmaceuticals
Publication of BR9708720A publication Critical patent/BR9708720A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA E PROCESSO PARA O TRATAMENTO DE DEMêNCIA POR HIV". As composições a base em benzamida são descritas para terem atividade como agentes terapêuticos e profiláticos no tratamento de condições associadas com infecção por vírus de HIV-1, referido a estágios avançados como demência associada com infecção por HIV ou demência por HIV."PHARMACEUTICAL COMPOSITION AND PROCESS FOR THE TREATMENT OF HIV DEMENTIA". Benzamide-based compositions are described to have activity as therapeutic and prophylactic agents in the treatment of conditions associated with HIV-1 virus infection, referred to advanced stages such as dementia associated with HIV infection or HIV dementia.

BR9708720-3A 1996-04-17 1997-04-17 Pharmaceutical composition and process for the treatment of HIV dementia. BR9708720A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1571096P 1996-04-17 1996-04-17
PCT/US1997/006351 WO1997038684A1 (en) 1996-04-17 1997-04-17 Benzamide treatment of dementia associated with aids virus (hiv-1) infection

Publications (1)

Publication Number Publication Date
BR9708720A true BR9708720A (en) 2000-01-04

Family

ID=21773101

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708720-3A BR9708720A (en) 1996-04-17 1997-04-17 Pharmaceutical composition and process for the treatment of HIV dementia.

Country Status (11)

Country Link
EP (1) EP0912171A1 (en)
CN (1) CN1218399A (en)
AP (1) AP898A (en)
AU (1) AU720578B2 (en)
BR (1) BR9708720A (en)
CA (1) CA2252403A1 (en)
IS (1) IS4868A (en)
NZ (1) NZ332438A (en)
OA (1) OA10901A (en)
TW (1) TW412421B (en)
WO (1) WO1997038684A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003211118A1 (en) 2002-02-13 2003-09-04 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
JP6750177B2 (en) * 2015-12-11 2020-09-02 ロート製薬株式会社 Anthranilamide derivative and therapeutic agent for diseases involving TLR3 containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions
IL117629A (en) * 1995-04-03 2000-08-13 Centaur Pharmaceuticals Inc Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof

Also Published As

Publication number Publication date
AU2732297A (en) 1997-11-07
CN1218399A (en) 1999-06-02
OA10901A (en) 2002-02-14
IS4868A (en) 1998-10-16
AP9801368A0 (en) 1998-12-31
NZ332438A (en) 2001-02-23
WO1997038684A1 (en) 1997-10-23
AU720578B2 (en) 2000-06-08
CA2252403A1 (en) 1997-10-23
EP0912171A1 (en) 1999-05-06
TW412421B (en) 2000-11-21
AP898A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
BR9909730A (en) Dihydropyrimidines
DE69727158D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSSLINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES
BR0013771A (en) Compound, methods of treating a viral infection in a mammal, inhibiting hiv reverse transcriptase, and preventing hiv infection or treating hiv infection, use of a compound, and, pharmaceutical composition
BR0008840A (en) Camptothecin derivatives having antitumor activity
PT1019040E (en) INHIBITION OF THE ACTIVITY OF P38-KINASE BY MEANS OF ARILUREIAS
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
BR0001468A (en) hydroxycanic dioxicyclopentyl acids
MD1507F2 (en) Inhibitors, pharmaceutical composition on base thereof and process for HIV protease inhibition
EA199901031A1 (en) Derivatives of benzimidazole
PT88930A (en) METHOD FOR THE PREPARATION OF NEW ANALYSES OF NUCLEOSIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69431972D1 (en) HIV protease inhibitors in pharmaceutical compositions for the treatment of AIDS
BR9808100A (en) Use of amandantine to treat hepatitis c.
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
HUP9602498A2 (en) Pharmaceutical compositions of antimicrobial activity
BR9711647A (en) New derivatives of Dicafeoilquímica, their use, compositions with them and treatment methods using them.
DE69430385D1 (en) HIV Protease Inhibitors
BR9814945A (en) Use of phanquinone for the treatment of alzheimer's disease, pharmaceutical composition and kit
MX9604762A (en) Novel sulfonamides and process for the preparation thereof.
DE60026883D1 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
FI922428A0 (en) NYA 2-AMINO-5-CYAN-1,4-DIHYDROPYRIDINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL.
BR9708720A (en) Pharmaceutical composition and process for the treatment of HIV dementia.
ATE309803T1 (en) SPHINGOMYELINASE INHIBITORS AS ACTIVE INGREDIENTS WITH ANTIAPOPTOTIC AND ANTISEPTIC EFFECTS
DE69010523D1 (en) Kit or composition for preventing or treating HIV-1 infections.
PT1411956E (en) UTILIZATION OF OVER-SULPHATED POLYNOSTAKERS AS HIV INHIBITORS
ES2190581T3 (en) 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK.

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal